These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36110386)

  • 21. Atomistic and Thermodynamic Analysis of N6-Methyladenosine (m
    Li Y; Bedi RK; Wiedmer L; Sun X; Huang D; Caflisch A
    J Chem Theory Comput; 2021 Feb; 17(2):1240-1249. PubMed ID: 33472367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YTHDF2 inhibit the tumorigenicity of endometrial cancer via downregulating the expression of IRS1 methylated with m
    Hong L; Pu X; Gan H; Weng L; Zheng Q
    J Cancer; 2021; 12(13):3809-3818. PubMed ID: 34093789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.
    Imam H; Kim GW; Mir SA; Khan M; Siddiqui A
    PLoS Pathog; 2020 Feb; 16(2):e1008338. PubMed ID: 32059034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased
    Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
    Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YTHDF2 Regulates Maternal Transcriptome Degradation and Embryo Development in Goat.
    Deng M; Chen B; Liu Z; Cai Y; Wan Y; Zhang G; Fan Y; Zhang Y; Wang F
    Front Cell Dev Biol; 2020; 8():580367. PubMed ID: 33117808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics.
    Xu M; Unzue A; Dong J; Spiliotopoulos D; Nevado C; Caflisch A
    J Med Chem; 2016 Feb; 59(4):1340-9. PubMed ID: 26125948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway.
    Zhao T; Wang M; Zhao X; Weng S; Qian K; Shi K; Gu Y; Ying W; Qian X; Zhang Y
    Front Oncol; 2022; 12():763341. PubMed ID: 35186724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response.
    Yu R; Li Q; Feng Z; Cai L; Xu Q
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors.
    Drinkwater N; Vu H; Lovell KM; Criscione KR; Collins BM; Prisinzano TE; Poulsen SA; McLeish MJ; Grunewald GL; Martin JL
    Biochem J; 2010 Oct; 431(1):51-61. PubMed ID: 20642456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selectively Disrupting m
    Bedi RK; Huang D; Wiedmer L; Li Y; Dolbois A; Wojdyla JA; Sharpe ME; Caflisch A; Sledz P
    ACS Chem Biol; 2020 Mar; 15(3):618-625. PubMed ID: 32101404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.
    Tsuchiya K; Yoshimura K; Inoue Y; Iwashita Y; Yamada H; Kawase A; Watanabe T; Tanahashi M; Ogawa H; Funai K; Shinmura K; Suda T; Sugimura H
    Oncoimmunology; 2021; 10(1):1962656. PubMed ID: 34408926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine.
    Zhu T; Roundtree IA; Wang P; Wang X; Wang L; Sun C; Tian Y; Li J; He C; Xu Y
    Cell Res; 2014 Dec; 24(12):1493-6. PubMed ID: 25412661
    [No Abstract]   [Full Text] [Related]  

  • 33. Discovery of a novel chemotype of tyrosine kinase inhibitors by fragment-based docking and molecular dynamics.
    Zhao H; Dong J; Lafleur K; Nevado C; Caflisch A
    ACS Med Chem Lett; 2012 Oct; 3(10):834-8. PubMed ID: 24900387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA.
    Kim GW; Siddiqui A
    J Virol; 2022 Feb; 96(4):e0165521. PubMed ID: 34851655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspases Switch off the m
    Zhang K; Zhang Y; Maharjan Y; Sugiokto FG; Wan J; Li R
    mBio; 2021 Aug; 12(4):e0170621. PubMed ID: 34425696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA m
    Li Y; Sheng H; Ma F; Wu Q; Huang J; Chen Q; Sheng L; Zhu X; Zhu X; Xu M
    Cell Death Dis; 2021 May; 12(5):479. PubMed ID: 33980824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. YTH Domain: A Family of N
    Liao S; Sun H; Xu C
    Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):99-107. PubMed ID: 29715522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YTHDF2 Suppresses Notch Signaling through Post-transcriptional Regulation on Notch1.
    Lee B; Lee S; Shim J
    Int J Biol Sci; 2021; 17(14):3776-3785. PubMed ID: 34671198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators.
    Fei Q; Zou Z; Roundtree IA; Sun HL; He C
    PLoS Biol; 2020 Apr; 18(4):e3000664. PubMed ID: 32267835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.